Difference between revisions of "Buserelin (Suprefact)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis. ==Di...") |
m |
||
(7 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Prostate cancer]] | *[[Prostate cancer]] | ||
+ | |||
+ | ==History of changes in EMA indication== | ||
+ | *1984-08-16: EURD | ||
+ | |||
+ | ==Also known as== | ||
+ | *'''Code names:''' HOE-766, ICI-123215, S74-6766 | ||
+ | *'''Brand names:''' Bigonist, Etilamide, Profact, Receptal, Suprecur, Suprefact | ||
+ | |||
+ | [[Category:Drugs]] | ||
+ | [[Category:Subcutaneous medications]] | ||
+ | [[Category:Nasal medications]] | ||
+ | |||
+ | [[Category:GnRH analogs]] | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
+ | |||
+ | [[Category:EMA approved in 1984]] | ||
[[Category:Stub]] | [[Category:Stub]] |
Latest revision as of 11:51, 23 September 2023
Mechanism of action
Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis.
Diseases for which it is used
History of changes in EMA indication
- 1984-08-16: EURD
Also known as
- Code names: HOE-766, ICI-123215, S74-6766
- Brand names: Bigonist, Etilamide, Profact, Receptal, Suprecur, Suprefact